camptothecin has been researched along with 3,3'-diindolylmethane in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Castelli, S; D'Annessa, I; Desideri, A | 1 |
| Andrews, NG; Deb, A; Raghavan, V | 1 |
1 review(s) available for camptothecin and 3,3'-diindolylmethane
| Article | Year |
|---|---|
Topoisomerase 1B as a target against leishmaniasis.
Topics: Antiprotozoal Agents; Camptothecin; DNA Topoisomerases, Type I; Humans; Indoles; Isoquinolines; Leishmania; Leishmaniasis; Naphthoquinones; Protozoan Proteins; Quercetin | 2015 |
2 other study(ies) available for camptothecin and 3,3'-diindolylmethane
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Natural polymer functionalized graphene oxide for co-delivery of anticancer drugs: In-vitro and in-vivo.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Biological Availability; Camptothecin; Cell Death; Drug Carriers; Drug Synergism; Female; Graphite; Hemolysis; Humans; Indoles; MCF-7 Cells; Nanocomposites; Oxides; Polymers; Rats; Rats, Wistar; Tissue Distribution | 2018 |